Skip to main content

Table 7 (abstract P375). Correlation of Tumor-infiltrating CD8+ T cells, PD-L1 status, and TME Immune Types with Clinicopathologic Features in 186 patients

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Characteristics

Tumor-infiltrating CD8+ T cell

PD-L1 status

TME Immune Types

  

IHC=0 (n)

IHC=1 (n)

IHC=2 (n)

IHC=3 (n(

P-value

TC=0 and IC=0 (n)

TC=1/2/3 or IC-1/2/3 (n)

P-value

Type I

Type II

Type IV

P-value

Sex

Male

16

45

54

13

0.874

52

76

0.728

76

16

36

0.901

Female

6

21

23

8

 

22

36

 

36

6

16

 

Age

<65

17

42

55

13

0.527

51

76

0.879

76

17

34

0.597

≥65

5

24

22

8

 

23

36

 

36

5

18

 

Histological grade

G1-G2

9

35

29

5

0.080

35

43

0.228

43

9

26

0.372

G3-G4

13

31

48

16

 

39

69

 

69

13

26

 

Stage

I

2

6

6

4

0.637

6

12

0.395

12

2

4

0.671

II

3

15

21

4

 

14

29

 

29

3

11

 

III

17

45

50

13

 

54

71

 

71

17

37

 

Tumor location

EGJ

6

29

29

6

0.414

29

41

0.722

41

6

23

0.364

Gastric

16

37

48

15

 

45

71

 

71

16

29

 
Back to article page